American Journal of Cardiology
Volume 93, Issue 1 , Pages 45-48 , 1 January 2004

Comparison of recurrence rates after direct-current cardioversion for new-onset atrial fibrillation in patients receiving versus those not receiving rhythm-control drug therapy

  • Huagui Li, MD, PhD

      Affiliations

    • The Cardiac Center of Creighton University, Omaha, Nebraska, USA
    • Corresponding Author InformationAddress for reprints: Huagui Li, MD, PhD, The Cardiac Center of Creighton University, 3006 Webster Street, Omaha, Nebraska 68131, USA.
    • ,
  • Roger Riedel, MD

      Affiliations

    • The Cardiac Center of Creighton University, Omaha, Nebraska, USA
    • ,
  • J.Bradley Oldemeyer, MD

      Affiliations

    • The Cardiac Center of Creighton University, Omaha, Nebraska, USA
    • ,
  • Karen Rovang, MD

      Affiliations

    • The Cardiac Center of Creighton University, Omaha, Nebraska, USA
    • ,
  • Tom Hee, MD

      Affiliations

    • The Cardiac Center of Creighton University, Omaha, Nebraska, USA

Received 27 June 2003 ,Revised 4 September 2003 ,Accepted 4 September 2003.

References 

  1. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators . A Comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–1833
  2. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJM, Tijssen JGP, Crijns JGM, for the Rate Control versus Electrical Cardioversion for Perisistent Atrial Fibrillation Study Group. N Engl J Med. 2002;347:1834–1840
  3. Van Gelder IC, Crijns HJGM, van Gilst WH, van Wijk LM, Hamer HPM, Lie KI. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. Am J Cardiol. 1989;64:1317–1321
  4. Juul-Moller S, Edvardsson N, Rehnqvist-Ahlberg N. Sotalol versus quinidine for maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation. 1990;82:1932–1939
  5. Gosselink ATM, Crijns HJGM, van Gelder IC, Hillige H, Wiesfeld ACP, Lie KI. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA. 1992;267:3289–3293
  6. Stroobandt R, Stiels B, Hoebrechts R  Propafenone Atrial Fibrillation Trial Investigators . Propafenone for conversion and prophylaxis of atrial fibrillation. Am J Cardiol. 1997;79:418–423
  7. Van Gelder IC, Crijns HJ, Tieleman RG, Brugemann J, De Kam PJ, Gosselink AT, et al. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Ann Intern Med. 1996;156:2585–2592

PII: S0002-9149(03)01326-2

doi: 10.1016/j.amjcard.2003.09.010

American Journal of Cardiology
Volume 93, Issue 1 , Pages 45-48 , 1 January 2004

Article Tools

* Image Usage & Resolution